| Product Name |
Lapatinib Inhouse Impurity 7 / Lapatinib Desmesylethylamino Hydroxy Impurity
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Pharmaceutical Standards, Fine Chemicals |
| CAS No |
320337-48-2 |
| Catalog Number |
GS.08.LAP.37 |
| Chemical Name/Synonyms |
Des(sulfonylethyl)amino Hydroxy Lapatinib ; (5-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)furan-2-yl)methanol ; 5-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furanmethanol |
| Molecular Weight |
475.9 |
| Molecular Formula |
C26H19ClFN3O3 |
| Purity |
NLT 95 % |
| Applications |
Lapatinib is used to treat breast cancer, especially metastatic breast cancer that has progressed after trastuzumab treatment and other chemotherapy. |
| Inventory Status |
customized
|
